Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  The Lancet Oncology

• Publication date

  2009-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S1470-2045(09)70154-8PMID 19515614PMCID PMC3045079
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: results of the SIOPEN study.

  2013cited by this paper
• Poor survival for infants with MYCN-amplified metastatic neuroblastoma despite intensified treatment: the International Society of Paediatric Oncology European Neuroblastoma Experience.

  2009cited by this paper
• Excellent outcome with reduced treatment for infants with disseminated neuroblastoma without MYCN gene amplification.

  2009cited by this paper
• Identification of low intratumoral gene expression heterogeneity in neuroblastic tumors by genome‐wide expression analysis and game theory

  2008cited by this paper
• RTPrimerDB: the portal for real-time PCR primers and probes

  2008cited by this paper
• Pathways connecting inflammation and cancer.

  2008cited by this paper
• Expression of the tumour suppressor gene CADM1 is associated with favourable outcome and inhibits cell survival in neuroblastoma

  2008cited by this paper
• CADM1 is a strong neuroblastoma candidate gene that maps within a 3.72 Mb critical region of loss on 11q23

  2008cited by this paper
• Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group

  2008cited by this paper
• A gene sets approach for identifying prognostic gene signatures for outcome prediction

  2008cited by this paper
• CHD5, a Tumor Suppressor Gene Deleted From 1p36.31 in Neuroblastomas

  2008cited by this paper
• ODC1 is a critical determinant of MYCN oncogenesis and a therapeutic target in neuroblastoma.

  2008cited by this paper
• The prognostic role of a gene signature from tumorigenic breast-cancer cells.

  2007cited by this paper
• A five-gene signature and clinical outcome in non-small-cell lung cancer.

  2007cited by this paper
• Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification.

  2006cited by this paper
• RNA integrity and the effect on the real-time qRT-PCR performance.

  2006cited by this paper
• Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number.

  2006cited by this paper
• SPUD: a quantitative PCR assay for the detection of inhibitors in nucleic acid preparations.

  2006cited by this paper
• Reduced Expression of CAMTA1 Correlates with Adverse Outcome in Neuroblastoma Patients

  2006cited by this paper
• Survivin mRNA Levels Are Associated With Biology of Disease and Patient Survival in Neuroblastoma: A Report From the Children's Oncology Group

  2006cited by this paper
• The challenges of gene expression microarrays for the study of human cancer.

  2006cited by this paper
• Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer.

  2005cited by this paper
• Expression profiling using a tumor-specific cDNA microarray predicts the prognosis of intermediate risk neuroblastomas.

  2005cited by this paper
• Imperfect protection: NEPA at 35 years.

  2004cited by this paper
• Oligonucleotide microarray analysis of gene expression in neuroblastoma displaying loss of chromosome 11q.

  2004cited by this paper
• Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling

  2004cited by this paper
• Diagnosis of multiple cancer types by shrunken centroids of gene expression

  2002cited by this paper
• Loss of a FYN-regulated differentiation and growth arrest pathway in advanced stage neuroblastoma.

  2002cited by this paper
• Gene expression profiling predicts clinical outcome of breast cancer

  2002cited by this paper

• Prediction of neuroblastoma prognosis with a novel T-cell exhaustion-related gene signature

  2025cites this paper
• Novel pan-cancer T cell exhaustion signature forecasts immunotherapy response and unveils BCAP31 in macrophages as a therapeutic target in neuroblastoma

  2025cites this paper
• Analysis of qPCR Data: From PCR Efficiency to Absolute Target Quantity

  2025cites this paper
• MoX: an explainable hybrid deep-learning model for integrating multi-omics data to predict event-free survival in neuroblastoma prognosis

  2025cites this paper
• Advancing Neuroblastoma Diagnosis: A Comprehensive Review of Computational Technologies and Methodologies for Data Analysis and Pattern Extraction

  2025cites this paper
• Introducing the f0% method: a reliable and accurate approach for qPCR analysis

  2024cites this paper
• Sustained cancer‐relevant alternative RNA splicing events driven by PRMT5 in high‐risk neuroblastoma

  2024cites this paper
• Proteomic analysis of serum small extracellular vesicles identifies diagnostic biomarkers for neuroblastoma

  2024cites this paper
• Long Non-Coding RNAs in Neuroblastoma: Pathogenesis, Biomarkers and Therapeutic Targets

  2024cites this paper
• Predicting Neuroblastoma Patient Risk Groups, Outcomes, and Treatment Response Using Machine Learning Methods: A Review

  2024influential citation
• Lineage specific transcription factor waves reprogram neuroblastoma from self-renewal to differentiation

  2024cites this paper
• Targeting long noncoding RNAs in neuroblastoma: Progress and prospects

  2023cites this paper
• Signature literature review reveals AHCY, DPYSL3, and NME1 as the most recurrent prognostic genes for neuroblastoma

  2023influential citation
• Development and validation of a 21-gene prognostic signature in neuroblastoma

  2023cites this paper
• Target Genes of c-MYC and MYCN with Prognostic Power in Neuroblastoma Exhibit Different Expressions during Sympathoadrenal Development

  2023cites this paper
• Multi-omics integration reveals a six-malignant cell maker gene signature for predicting prognosis in high-risk neuroblastoma

  2022cites this paper
• Chromosome instability in neuroblastoma: A pathway to aggressive disease

  2022cites this paper
• MIT Open

  2022cites this paper
• A G316A Polymorphism in the Ornithine Decarboxylase Gene Promoter Modulates MYCN-Driven Childhood Neuroblastoma

  2021cites this paper
• Cq values do not reflect nucleic acid quantity in biological samples.

  2021cites this paper
• Efficiency-correction is required for accurate qPCR analysis and reporting.

  2021cites this paper
• Non-Coding RNAs Participate in the Pathogenesis of Neuroblastoma

  2021cites this paper
• A Deep-Learning Model With the Attention Mechanism Could Rigorously Predict Survivals in Neuroblastoma

  2021cites this paper
• The Role of Extracellular Vesicles in the Progression of Human Neuroblastoma

  2021cites this paper
• Identification of a Five-Gene Signature Derived From MYCN Amplification and Establishment of a Nomogram for Predicting the Prognosis of Neuroblastoma

  2021cites this paper
• Evaluation validation of a qPCR curve analysis method and conventional approaches

  2020cites this paper
• Gene signatures associated with genomic aberrations predict prognosis in neuroblastoma

  2020cites this paper
• Prognostic significance of MYCN related genes in pediatric neuroblastoma: a study based on TARGET and GEO datasets

  2020cites this paper
• New Prognostic Indicators in Pediatric Adrenal Tumors: Neuroblastoma and Adrenal Cortical Tumors, Can We Predict When These Will Behave Badly?

  2020cites this paper
• Prp19 Is an Independent Prognostic Marker and Promotes Neuroblastoma Metastasis by Regulating the Hippo-YAP Signaling Pathway

  2020cites this paper
• Lineage specific transcription factor waves reprogram neuroblastoma from self-renewal to differentiation

  2020cites this paper
• The Impact of Pretransplant Disease Characteristics on the Outcome of Autologous Stem Cell Transplantation for Neuroblastoma with High-Risk Features: A Retrospective Model from a Limited Resources Country

  2019cites this paper
• Non-High-Risk Neuroblastoma: Classification and Achievements in Therapy

  2019cites this paper
• A novel data processing method CyC* for quantitative real time polymerase chain reaction minimizes cumulative error

  2019cites this paper
• Biology of Neuroblastoma

  2019cites this paper
• Metabolomic profiling in neuroblastoma

  2019cites this paper
• The Transcribed-Ultra Conserved Regions: Novel Non-Coding RNA Players in Neuroblastoma Progression

  2019cites this paper
• Identifying a ten-microRNA signature as a superior prognosis biomarker in colon adenocarcinoma

  2019cites this paper
• The challenge of defining “ultra‐high‐risk” neuroblastoma

  2018cites this paper
• Predicting neuroblastoma using developmental signals and a logic-based model.

  2018cites this paper
• Too many targets, not enough patients: rethinking neuroblastoma clinical trials

  2018cites this paper
• Predicting clinical outcomes in neuroblastoma with genomic data integration

  2018cites this paper
• Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients

  2018cites this paper
• Neuroblastoma

  2018cites this paper
• EZH2 regulates neuroblastoma cell differentiation via NTRK1 promoter epigenetic modifications

  2018cites this paper
• High-risk, Expression-Based Prognostic Long Noncoding RNA Signature in Neuroblastoma

  2018cites this paper
• Analysis of the risk factor for the poor prognosis of localized neuroblastoma after the surgical

  2018cites this paper
• Distillation of the clinical algorithm improves prognosis by multi-task deep learning in high-risk Neuroblastoma

  2018cites this paper
• Neuroblastoma cells undergo transcriptomic alterations upon dissemination into the bone marrow and subsequent tumor progression

  2017cites this paper
• Identification of Plagl1/Zac1 binding sites and target genes establishes its role in the regulation of extracellular matrix genes and the imprinted gene network

  2017cites this paper
• The Origin of Neuroblastoma

  2017cites this paper
• The Origin of Neuroblastoma The Origin of Neuroblastoma

  2017cites this paper
• 11 Neuroblastoma and Whole Genome Searches

  2017cites this paper
• Creación de un pipeline para el análisis de datos procedentes de PCR cuantitativa

  2017cites this paper
• A unified censored normal regression model for qPCR differential gene expression analysis

  2017cites this paper
• Immunohistochemical analysis of PDK1, PHD3 and HIF-1α expression defines the hypoxic status of neuroblastoma tumors

  2017cites this paper
• A c-Myc-regulated stem cell-like signature in high-risk neuroblastoma: A systematic discovery (Target neuroblastoma ESC-like signature)

  2017cites this paper
• Kinome expression profiling of human neuroblastoma tumors identifies potential drug targets for ultra high-risk patients

  2017cites this paper
• A multiobjective deep learning approach for predictive classification in Neuroblastoma

  2017cites this paper
• Molecular Classification Substitutes for the Prognostic Variables Stage, Age, and MYCN Status in Neuroblastoma Risk Assessment

  2017cites this paper
• Coexpression network analysis identifies transcriptional modules associated with genomic alterations in neuroblastoma.

  2017cites this paper
• Transcription instability in high‐risk neuroblastoma is associated with a global perturbation of chromatin domains

  2017cites this paper
• The role of omics in neuroblastoma: Patient’s risk classification and personalised therapy

  2016cites this paper
• Neuroblastoma messenger RNA is frequently detected in bone marrow at diagnosis of localised neuroblastoma patients.

  2016cites this paper
• Artificial neural network classifier predicts neuroblastoma patients’ outcome

  2016cites this paper
• Neuroblastoma (Peripheral neuroblastic tumours).

  2016cites this paper
• Neuroblastoma, children, neural nancy of crest-derived infants accounts an and aggressive for malig- young a large Neuroblastoma, neural crest-derived malig-

  2016cites this paper
• Straightforward and sensitive RT-qPCR based gene expression analysis of FFPE samples

  2016cites this paper
• An 18 gene expression-based score classifier predicts the clinical outcome in stage 4 neuroblastoma

  2016cites this paper
• Minimal residual disease monitoring in neuroblastoma

  2016cites this paper
• Comparison of RNA-seq and microarray-based models for clinical endpoint prediction

  2015cites this paper
• Advances in Risk Classification and Treatment Strategies for Neuroblastoma.

  2015cites this paper
• Expression of FOXP3, CD14, and ARG1 in Neuroblastoma Tumor Tissue from High-Risk Patients Predicts Event-Free and Overall Survival

  2015cites this paper
• Chapter 2 Oncogenic Activation Of FOXR 1 By 11 q 23 Intrachromosomal Deletion-Fusions In Neuroblastoma

  2015cites this paper
• Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma

  2015cites this paper
• Tumor-AssociatedMacrophages in SHHSubgroup of Medulloblastomas

  2015cites this paper
• Enriched Bone Marrow Derived Disseminated Neuroblastoma Cells Can Be a Reliable Source for Gene Expression Studies—A Validation Study

  2015cites this paper
• Individual patient risk stratification of high‐risk neuroblastomas using a two‐gene score suited for clinical use

  2015cites this paper
• Outcome in Neuroblastoma

  2015cites this paper
• Neuroblastoma: paradigm for precision medicine.

  2015cites this paper
• Metronomic topotecan impedes tumor growth of MYCN-amplified neuroblastoma cells in vitro and in vivo by therapy induced senescence

  2015cites this paper
• Two independent epigenetic biomarkers predict survival in neuroblastoma

  2015cites this paper
• Tumor-Associated Macrophages in SHH Subgroup of Medulloblastomas

  2014cites this paper
• Galectin-3 is a marker of favorable prognosis and a biologically relevant molecule in neuroblastic tumors

  2014cites this paper
• Use of Attribute Driven Incremental Discretization and Logic Learning Machine to build a prognostic classifier for neuroblastoma patients

  2014cites this paper
• Identifying Rare Events in Rare Diseases

  2014cites this paper
• Chapter 21 – Neuroblastoma

  2014cites this paper
• Neuroblastoma mRNAs predict outcome in children with stage 4 neuroblastoma: a European HR-NBL1/SIOPEN study.

  2014cites this paper
• Role Mikrorna V Patofyziologii Neuroblastomu a Možnosti Jejich Využití pro Dia Gnostiku, Odhad Prognózy a Terapii Th E Role of Micrornas in the Pathophysiology of Neuroblastoma and Th Eir Possible Use in Dia Gnosis, Prognosis and Th Erapy

  2014cites this paper
• Role mikroRNA v patofyziologii neuroblastomu a možnosti jejich využití pro dia gnostiku, odhad prognózy a terapii Th e Role of MicroRNAs in the Pathophysiology of Neuroblastoma and Th eir Possible Use in Dia gnosis, Prognosis and Th erapy

  2014cites this paper
• Selection of reliable reference genes for RT-qPCR analysis.

  2014cites this paper
• METHOD Open Access

  2014cites this paper
• Recent insights into the biology of neuroblastoma

  2014cites this paper
• Validation of a prognostic multi‐gene signature in high‐risk neuroblastoma using the high throughput digital NanoString nCounter™ system

  2014cites this paper
• MAKERGAUL: an innovative MAK2-based model and software for real-time PCR quantification.

  2014cites this paper
• Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

  2014cites this paper
• An extension of the Wilcoxon-Mann-Whitney test for analyzing RT-qPCR data

  2013cites this paper
• Expressional alterations in functional ultra-conserved non-coding rnas in response to all-trans retinoic acid - induced differentiation in neuroblastoma cells

  2013cites this paper
• snoRNPs Regulate Telomerase Activity in Neuroblastoma and Are Associated with Poor Prognosis.

  2013cites this paper
• Pathologie der Kindertumoren

  2013cites this paper